AOC3 and Hyperglycemia: Research has shown that VAP-1 substrates, such as benzylamine, combined with low-dose vanadate, improve glucose tolerance by enhancing glucose transporter-4 (GLUT-4) expression in adipocytes and reducing hyperglycemia (87).